Related Experiment Video
Updated: Feb 24, 2026

06:53
Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells
Published on: June 2, 2022
3.8K
Ginkgo Datapoints Antibody Developability Competition outcomes: limited model performance and a call for data
Lood van Niekerk1, Joshua Moller1, Seth Ritter1
1Ginkgo Bioworks Inc, Boston, MA, USA.
Mabs
|February 22, 2026
Summary
The Antibody Developability (AbDev) Competition benchmarked prediction models for antibody properties. Current models overfit small datasets, limiting generalization and highlighting the need for larger, standardized experimental data for antibody discovery.
Area of Science:
- Biotechnology
- Computational Biology
- Drug Discovery
Background:
- Antibody developability is crucial for successful drug development.
- Predicting antibody developability computationally is an active area of research.
- Existing datasets for model training are often small and heterogeneous.
Purpose of the Study:
- To benchmark computational models for predicting antibody developability.
- To assess the generalization capabilities of these models on unseen data.
- To identify limitations and future directions for antibody developability prediction.
Main Methods:
- Conducted the blinded Ginkgo Datapoints Antibody Developability (AbDev) Competition.
- Evaluated predictors on five biophysical properties: hydrophobicity, thermostability, self-association, expression titer, and polyreactivity.
- Used a public training set (246 antibodies) and a held-out test set (80 antibodies).
Main Results:
- Top performance varied by property, with hydrophobicity prediction being strongest (Spearman's ρ = 0.708).
- Cross-validation scores on training data consistently outperformed test set performance, indicating overfitting.
- Limited out-of-distribution generalization was observed across predictors.
Conclusions:
- Current antibody developability models show limited generalization due to small, heterogeneous datasets.
- Larger, standardized, and diverse experimental datasets with harmonized protocols are essential for robust model training and validation.
- Future antibody discovery campaigns require reliable, generalizable developability prediction models.

